Gut microbiome and inflammation among athletes in wheelchair in a crossover randomized pilot trial of probiotic and prebiotic interventions
- PMID: 38834634
- PMCID: PMC11150429
- DOI: 10.1038/s41598-024-63163-z
Gut microbiome and inflammation among athletes in wheelchair in a crossover randomized pilot trial of probiotic and prebiotic interventions
Abstract
Disorders related to gut health are a significant cause of morbidity among athletes in wheelchair. This pilot feasibility trial aims to investigate whether probiotics compared to prebiotics can improve inflammatory status and gut microbiome composition in elite athletes in wheelchair. We conducted a 12-week, randomized, cross-over controlled trial involving 14 elite Swiss athletes in wheelchair. Participants were given a multispecies-multistrain probiotic or prebiotic (oat bran) daily for 4 weeks (Clinical trials.gov NCT04659408 09/12/2020). This was followed by a 4-week washout and then crossed over. Thirty inflammatory markers were assessed using bead-based multiplex immunoassays (LegendPlex) from serum samples. The gut microbiome was characterized via 16S rRNA sequencing of stool DNA samples. Statistical analyses were conducted using linear mixed-effect models (LMM). At baseline, most athletes (10/14) exhibited low levels of inflammation which associated with higher gut microbiome alpha diversity indices compared to those with high inflammation levels. The use of probiotic had higher decrease in 25 (83%) inflammatory markers measured compared to prebiotic use. Probiotic has the potential in lowering inflammation status and improving the gut microbiome diversity. The future trial should focus on having sufficient sample sizes, population with higher inflammation status, longer intervention exposure and use of differential abundance analysis.
Keywords: Inflammation; Inflammatory markers; Linear mixed-effect models; Metabolism; Microbiome; Prebiotics; Probiotics; Spinal cord injury.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11150429/bin/41598_2024_63163_Fig1_HTML.gif)
Similar articles
-
The feasibility of a randomized controlled crossover trial to assess the effect of probiotic and prebiotic supplementation on the health of elite wheelchair athletes.Pilot Feasibility Stud. 2023 Jun 15;9(1):99. doi: 10.1186/s40814-023-01339-6. Pilot Feasibility Stud. 2023. PMID: 37322538 Free PMC article.
-
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2. Cochrane Database Syst Rev. 2022. PMID: 36126902 Free PMC article. Review.
-
The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies.Int J Mol Sci. 2022 Apr 19;23(9):4494. doi: 10.3390/ijms23094494. Int J Mol Sci. 2022. PMID: 35562885 Free PMC article. Review.
-
The feasibility of a crossover, randomized controlled trial design to assess the effect of probiotics and prebiotics on health of elite Swiss para-athletes: a study protocol.Pilot Feasibility Stud. 2022 Apr 27;8(1):94. doi: 10.1186/s40814-022-01048-6. Pilot Feasibility Stud. 2022. PMID: 35477496 Free PMC article.
-
Microbiota Stability and Gastrointestinal Tolerance in Response to a High-Protein Diet with and without a Prebiotic, Probiotic, and Synbiotic: A Randomized, Double-Blind, Placebo-Controlled Trial in Older Women.J Acad Nutr Diet. 2020 Apr;120(4):500-516.e10. doi: 10.1016/j.jand.2019.12.009. J Acad Nutr Diet. 2020. PMID: 32199523 Clinical Trial.